Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma

American Surgeon

Volumn 77, Issue 5, 2011, Pages 572-578

  Hayashi, Michihiro ^a   Shimizu, Tetsunosuke ^a   Hirokawa, Fumitoshi ^a   Inoue, Yoshihiro ^a   Komeda, Koji ^a   Asakuma, Mitsuhiro ^a   Miyamoto, Yoshiharu ^a   Takeshita, Atsushi ^a   Shibayama, Yuro ^a   Tanigawa, Nobuhiko ^a  

^a OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTIVITAMIN K;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TUMOR VOLUME; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79958088357     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kubo S, Nishiguti S, Hirohashi K, et al. High prevalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan. Hepatogastroenterology 1999;46:357-9. (Pubitemid 29154776)
2. Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. Am Coll Surg 2006;202:275-83. (Pubitemid 43112487)
3. Hasegawa K, Takayama T, Ijichi M, et al. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology 2006;44:891-5. (Pubitemid 46489553)
4. Ishii H, Yamamoto J, Ikari T. Adjuvant treatments for resectable hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008;15:459-62.
5. Sobin LH, Gospodarowicz MK, Wittekind C. UICC International Union Against Cancer: TNM Classification of Malignant Tumours, 7th ed. Chichester, UK: Wiley-Blackwell; 2009.
6. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9. (Pubitemid 26079803)
7. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer (English edition). Tokyo: Kanehara & Co, Ltd; 1997.
8. Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005;242:252-9. (Pubitemid 41033442)
9. Matsumoto K, Yoshimoto J, Sugo H, et al. Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C. Hepatol Res 2002;23:196-201. (Pubitemid 36104398)
10. Lu X, Zhat H, Yang H, et al. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol 2009;100:488-93.
11. Regimbeu JR, Abdalla EK, Vauthey JN, et al. Risk factor for early death due to recurrence after liver resection for hepatocellular carcinoma: result of multicenter study. J Surg Oncol 2004;85:36-41. (Pubitemid 38036738)
12. Choi GH, Kim DH, Kang CM, et al. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol 2008;15:618-29.
13. Jwo SC, Chiu JH, Chau GY, et al. Risk factor linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992;16:1367-71.
14. Nanashima A, Tanaka K, Yamaguchi H, et al. Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Dig Dis Sci 2003;48:1517-22. (Pubitemid 36936687)
15. Ko S, Kanehiro H, Hisanaga M, et al. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 2002;89:57-62. (Pubitemid 34031308)
16. Park JH, Koh KC, Choi MS, et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg 2006;192:29-33. (Pubitemid 43849602)
17. Tralhão JG, Kayal S, Dagher I, et al. Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients. Hepatogastroenterology 2007;54:1200-6. (Pubitemid 47013935)
18. Koike Y, Shiratori Y, Sato S, et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001;91:561-9. (Pubitemid 32105702)
19. Toyoda H, Kumada T, Kiriyama S, et al. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:111-7. (Pubitemid 43129532)
20. Fujiki M, Takada Y, Ogura Y, et al. Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant 2009;9:2362-71.
21. Toyoda H, Kumada T, Kaneoka Y, et al. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. J Hepatol 2008;49:223-32.
22. Sakon M, Nagano H, Nakamori S, et al. Intrahepatic recurrence of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 2002;137:94-9. (Pubitemid 34041828)
23. Kurokawa Y, Matoba R, Nagano H, et al. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma. Clin Cancer Res 2004;15:6029-38. (Pubitemid 39287507)
24. Lin MC, Wu CC, Cheng SB, et al. The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion. World J Surg 2007;31:1469-73.
25. Uenishi T, Nishiguchi S, Tanaka S, et al. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 2008;98:358-62.
26. Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepato-cellular carcinoma: a reappraisal. Br J Surg 1995;82:122-6.
27. Zhong C, Guo RP, Li JQ, et al. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemo-embolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol 2009;135:1437-45.